LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 98 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2018. The put-call ratio across all filers is 2.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $276,000 | – | 9,259 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN | 240,000 | $1,116,000 | 99.38% |
| TANG CAPITAL MANAGEMENT LLC | 9,607,934 | $44,677,000 | 8.98% |
| HealthInvest Partners AB | 830,000 | $3,860,000 | 5.44% |
| RTW INVESTMENTS, LP | 2,327,903 | $10,825,000 | 0.16% |
| GLOBEFLEX CAPITAL L P | 185,598 | $864,000 | 0.09% |
| WealthTrust Axiom LLC | 25,400 | $118,000 | 0.04% |
| HOLLENCREST CAPITAL MANAGEMENT | 82,355 | $383,000 | 0.03% |
| FIRST MIDWEST BANK TRUST DIVISION | 41,731 | $194,000 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 435,387 | $2,023,000 | 0.01% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 17,176 | $80,000 | 0.01% |